
The FDA appears likely to approve a second coronavirus vaccine later this week, this one from Moderna following the emergency use authorization approval that Pfizer received a few days ago. That's according to Dr. Moncef Slaoui, the head of the federal government's Operation Warp Speed vaccine program. Moderna's coronavirus vaccine has been found to have an efficacy rate of about 94%, and Dr. Slaoui said the hope is to have 100 million people immunized through the first quarter of 2021. Days aft...
Share this Article
Comment on this Article
Please to comment